The store will not work correctly when cookies are disabled.
(2-fluorophenyl)(2-hydroxy-4,6-dimethoxy-3-(pyrrolidin-1-ylmethyl)phenyl)methanone
ID: ALA1089358
PubChem CID: 46884270
Max Phase: Preclinical
Molecular Formula: C20H22FNO4
Molecular Weight: 359.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2ccccc2F)c(O)c1CN1CCCC1
Standard InChI: InChI=1S/C20H22FNO4/c1-25-16-11-17(26-2)18(19(23)13-7-3-4-8-15(13)21)20(24)14(16)12-22-9-5-6-10-22/h3-4,7-8,11,24H,5-6,9-10,12H2,1-2H3
Standard InChI Key: TUUBZJCYBDWIRY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
17.0361 -3.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0349 -4.1732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7497 -4.5860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4662 -4.1727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4633 -3.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7479 -2.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3201 -4.5851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6060 -4.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7455 -2.1080 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4587 -1.6934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1813 -4.5841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1762 -2.9270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8922 -3.3368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1731 -2.1020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8920 -4.1594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6072 -4.5692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3211 -4.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3153 -3.3247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5995 -2.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5922 -2.0937 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.7495 -5.4110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0350 -5.8234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2819 -5.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7297 -6.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1421 -6.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9490 -6.6470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
19 20 1 0
9 10 1 0
3 21 1 0
2 3 1 0
21 22 1 0
22 23 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.40 | Molecular Weight (Monoisotopic): 359.1533 | AlogP: 3.38 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.00 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.96 | CX Basic pKa: 7.93 | CX LogP: 2.76 | CX LogD: 2.73 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.80 | Np Likeness Score: -0.45 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |